Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-TAT-2021-Virtual-Congress-1000x250px
Start date
28 Feb 2021
End date
02 Mar 2021

ESMO Targeted Anticancer Therapies Virtual Congress 2021: the Home of Phase I in Oncology

The ESMO Targeted Anticancer Therapies Virtual Congress 2021, known as “The Home of Phase I in Oncology” offered participants a glimpse of the future of targeted anticancer therapies. 

It is the premier international meeting which focused on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development.

Stakeholders from academy and industry discussed with clinicians, researchers and regulators, the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.

Tablet block

Meeting Resources

Abstracts are published as soon as they are released and are open access.

Programme

Programme

The ESMO TAT Virtual Congress 2021 virtual programme is now online!

TAT-Congress-2021-Lounge-1200x451

YO Virtual Lounge Discussions

The Virtual Lounges are live virtual networking areas where you can meet peers and KOLs, during breaks and outside official programme times.

TAT-2021-Congress-1000x1000

Sponsors

Find out more information about the sponsors of TAT 2021

Contacts

Contacts

Get in touch with the organisers of TAT 2021.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings